The state of emergency department extracorporeal cardiopulmonary resuscitation: Where are we now, and where are we going?
Anna L CiulloJoseph E TonnaPublished in: Journal of the American College of Emergency Physicians open (2024)
Extracorporeal cardiopulmonary resuscitation (ECPR) has emerged in the context of the emergency department as a life-saving therapy for patients with refractory cardiac arrest. This review examines the utility of ECPR based on current evidence gleaned from three pivotal trials: the ARREST trial, the Prague study, and the INCEPTION trial. We also discuss several considerations in the care of these complex patients, including prehospital strategy, patient selection, and postcardiac arrest management. Collectively, the evidence from these trials emphasizes the growing significance of ECPR as a viable intervention, highlighting its potential for improved outcomes and survival rates in patients with refractory cardiac arrest when employed judiciously. As such, these findings advocate the need for further research and protocol development to optimize its use in diverse clinical scenarios.
Keyphrases
- cardiopulmonary resuscitation
- cardiac arrest
- emergency department
- randomized controlled trial
- study protocol
- end stage renal disease
- clinical trial
- phase iii
- newly diagnosed
- ejection fraction
- healthcare
- cell cycle
- phase ii
- chronic kidney disease
- palliative care
- quality improvement
- case report
- adverse drug
- cell proliferation
- adipose tissue
- open label
- chronic pain
- glycemic control
- electronic health record
- weight loss